PharmaLundensis
0,20 SEK
+16,28 %
Mindre end 1K følgere
PHAL
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
+16,28 %
-8,26 %
-18,70 %
-18,70 %
-66,67 %
-78,17 %
-58,52 %
-76,79 %
-93,90 %
PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.
Læs mereMarkedsværdi
12,86 mio. SEK
Aktieomsætning
200 SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
21.5
2026
Delårsrapport Q1'26
20.8
2026
Delårsrapport Q2'26
19.11
2026
Delårsrapport Q3'26